223 related articles for article (PubMed ID: 20181942)
1. p35 is required for CDK5 activation in cellular senescence.
Mao D; Hinds PW
J Biol Chem; 2010 May; 285(19):14671-80. PubMed ID: 20181942
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
Eggers JP; Grandgenett PM; Collisson EC; Lewallen ME; Tremayne J; Singh PK; Swanson BJ; Andersen JM; Caffrey TC; High RR; Ouellette M; Hollingsworth MA
Clin Cancer Res; 2011 Oct; 17(19):6140-50. PubMed ID: 21825040
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of p35 in Min6 pancreatic beta cells induces a stressed neuron-like apoptosis.
Zheng YL; Hu YF; Zhang A; Wang W; Li B; Amin N; Grant P; Pant HC
J Neurol Sci; 2010 Dec; 299(1-2):101-7. PubMed ID: 20926102
[TBL] [Abstract][Full Text] [Related]
4. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
[TBL] [Abstract][Full Text] [Related]
5. p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.
Bankston AN; Li W; Zhang H; Ku L; Liu G; Papa F; Zhao L; Bibb JA; Cambi F; Tiwari-Woodruff SK; Feng Y
J Biol Chem; 2013 Jun; 288(25):18047-57. PubMed ID: 23645679
[TBL] [Abstract][Full Text] [Related]
6. Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia.
Bosutti A; Qi J; Pennucci R; Bolton D; Matou S; Ali K; Tsai LH; Krupinski J; Petcu EB; Montaner J; Al Baradie R; Caccuri F; Caruso A; Alessandri G; Kumar S; Rodriguez C; Martinez-Gonzalez J; Slevin M
PLoS One; 2013; 8(9):e75538. PubMed ID: 24098701
[TBL] [Abstract][Full Text] [Related]
7. p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.
Zhang L; Liu W; Szumlinski KK; Lew J
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20041-6. PubMed ID: 23151508
[TBL] [Abstract][Full Text] [Related]
8. Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.
Yamada M; Saito T; Sato Y; Kawai Y; Sekigawa A; Hamazumi Y; Asada A; Wada M; Doi H; Hisanaga SI
J Neurochem; 2007 Sep; 102(5):1477-1487. PubMed ID: 17394551
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β1 induces cell cycle arrest by activating atypical cyclin-dependent kinase 5 through up-regulation of Smad3-dependent p35 expression in human MCF10A mammary epithelial cells.
Park SJ; Yang SW; Kim BC
Biochem Biophys Res Commun; 2016 Apr; 472(3):502-7. PubMed ID: 26966064
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration.
Lampropoulou E; Logoviti I; Koutsioumpa M; Hatziapostolou M; Polytarchou C; Skandalis SS; Hellman U; Fousteris M; Nikolaropoulos S; Choleva E; Lamprou M; Skoura A; Megalooikonomou V; Papadimitriou E
Sci Rep; 2018 Apr; 8(1):5893. PubMed ID: 29651006
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of ezrin by cyclin-dependent kinase 5 induces the release of Rho GDP dissociation inhibitor to inhibit Rac1 activity in senescent cells.
Yang HS; Hinds PW
Cancer Res; 2006 Mar; 66(5):2708-15. PubMed ID: 16510591
[TBL] [Abstract][Full Text] [Related]
12. Cdk5 interacts with Hif-1α in neurons: a new hypoxic signalling mechanism?
Antoniou X; Gassmann M; Ogunshola OO
Brain Res; 2011 Mar; 1381():1-10. PubMed ID: 20977891
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators.
Saito T; Yano M; Kawai Y; Asada A; Wada M; Doi H; Hisanaga SI
J Biol Chem; 2013 Nov; 288(45):32433-32439. PubMed ID: 24085300
[TBL] [Abstract][Full Text] [Related]
14. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.
Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH
J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541
[TBL] [Abstract][Full Text] [Related]
15. Enhanced activation of Ca2+/calmodulin-dependent protein kinase II upon downregulation of cyclin-dependent kinase 5-p35.
Hosokawa T; Saito T; Asada A; Ohshima T; Itakura M; Takahashi M; Fukunaga K; Hisanaga S
J Neurosci Res; 2006 Sep; 84(4):747-54. PubMed ID: 16802322
[TBL] [Abstract][Full Text] [Related]
16. Interplay between MEK-ERK signaling, cyclin D1, and cyclin-dependent kinase 5 regulates cell cycle reentry and apoptosis of neurons.
Modi PK; Komaravelli N; Singh N; Sharma P
Mol Biol Cell; 2012 Sep; 23(18):3722-30. PubMed ID: 22833568
[TBL] [Abstract][Full Text] [Related]
17. Cellular senescence requires CDK5 repression of Rac1 activity.
Alexander K; Yang HS; Hinds PW
Mol Cell Biol; 2004 Apr; 24(7):2808-19. PubMed ID: 15024070
[TBL] [Abstract][Full Text] [Related]
18. Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia.
Ito Y; Asada A; Kobayashi H; Takano T; Sharma G; Saito T; Ohta Y; Amano M; Kaibuchi K; Hisanaga S
Mol Cell Neurosci; 2014 Jul; 61():34-45. PubMed ID: 24877974
[TBL] [Abstract][Full Text] [Related]
19. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
Asada A; Saito T; Hisanaga S
J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
